| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 12/03/2013 | US8598429 Maize variety hybrid X03B467 |
| 12/03/2013 | US8598414 Soybean cultivar CL0911705-2 |
| 12/03/2013 | US8598409 Non-human organism comprising a gene expression modulation system encoding a chimeric retinoid X receptor |
| 12/03/2013 | US8598331 CLDN5 mini-promoters |
| 12/03/2013 | US8598318 Modified human thymic stromal lymphopoietin |
| 12/03/2013 | US8598171 Compositions and methods for prevention and treatment of amyloid-β peptide-related disorders |
| 12/03/2013 | US8598145 Mitochondrially delivered anti-cancer compounds |
| 12/03/2013 | US8598135 Insulin-like growth factor binding protein 7 for treatment of cancer |
| 12/03/2013 | US8598126 Peptides for inhibiting the HPV-E6 oncoprotein |
| 12/03/2013 | US8598122 Antagonistic peptides for frizzled-1 and frizzled-2 |
| 12/03/2013 | US8597950 Two-component RNA virus-derived plant expression system |
| 12/03/2013 | US8597949 Methods and compositions for modulating RAD51 and homologous recombination |
| 12/03/2013 | US8597948 Cloned biological material medical device and method thereof |
| 12/03/2013 | US8597947 Undifferentiated stem cell culture systems |
| 12/03/2013 | US8597946 Enhanced dendritic cells for cancer immunotherapy |
| 12/03/2013 | US8597944 Culture systems for ex vivo development |
| 12/03/2013 | US8597943 Method for improved single cell cloning |
| 12/03/2013 | US8597910 DNA encoding Von Willebrand Factor (VWF) and methods and cells for producing VFW, and VFW produced by the DNA, methods and cells |
| 12/03/2013 | US8597904 Pharmaceutical compositions for the treatment of conditions responsive to proteasome inhibition |
| 12/03/2013 | US8597898 Fusion polypeptides capable of activating receptors |
| 12/03/2013 | US8597895 Genes with ES cell-specific expression |
| 12/03/2013 | US8597877 Polymorphic loci that differentiate Escherichia coli O157:H7 from other strains |
| 12/03/2013 | US8597657 Mutated env sequence involved in the modulation of the immunosuppressive effect of viral proteins |
| 12/03/2013 | US8597648 Fully human anti-TNF-alpha monoclonal antibody, preparation method and use thereof |
| 12/03/2013 | CA2602050C Production of tissue engineered heart valves |
| 12/03/2013 | CA2555714C Methods for preparing t-cells for cell therapy |
| 12/03/2013 | CA2540969C Cell permeable structural implant |
| 12/03/2013 | CA2539457C Nucleic acid and gene derived from novel hcv strain and replicon-replicating cell using said gene |
| 12/03/2013 | CA2507592C Magnetism based rapid cell separation |
| 12/03/2013 | CA2501280C Cell culture |
| 12/03/2013 | CA2487765C Transgenic clawed frog embryos and use thereof as detectors of endocrine disrupters in the environment |
| 12/03/2013 | CA2474497C Compositions and methods related to tim-3, a th1-specific cell surface molecule |
| 12/03/2013 | CA2397207C Novel stra6 polypeptides |
| 12/03/2013 | CA2213610C Ingap protein involved in pancreatic islet neogenesis |
| 11/28/2013 | WO2013176916A1 Use of pre t alpha or functional variant thereof for expanding tcr alpha deficient t cells |
| 11/28/2013 | WO2013176915A1 Methods for engineering allogeneic and immunosuppressive resistant t cell for immunotherapy |
| 11/28/2013 | WO2013176772A1 Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription |
| 11/28/2013 | WO2013176538A2 Tenogenic medium for mesenchymal stem cells differentation into tenogenic lineage |
| 11/28/2013 | WO2013176322A1 Composition for promoting stem cell proliferation comprising phloridzin isolated from acanthopanax senticosus harms (araliaceae) extract |
| 11/28/2013 | WO2013176249A1 Method for producing pancreatic hormone-producing cell, pancreatic hormone-producing cell, and differentiation/induction promoter |
| 11/28/2013 | WO2013176233A1 Highly efficient method for establishing artificial pluripotent stem cell |
| 11/28/2013 | WO2013176197A1 Method for producing antigen-specific t cells |
| 11/28/2013 | WO2013176157A1 Formate dehydrogenase mutant, and use thereof |
| 11/28/2013 | WO2013176131A1 Template base for use in production of artificial tissue body for transplantation |
| 11/28/2013 | WO2013175759A1 New revascularization cell group derived from human monocytes, and technique for inducing differentiation thereof |
| 11/28/2013 | WO2013175321A1 Plants having one or more enhanced yield-related traits and method for making same |
| 11/28/2013 | WO2013175258A1 Novel melanoma antigen peptide and uses thereof |
| 11/28/2013 | WO2013175256A1 Novel melanoma antigen peptide and uses thereof |
| 11/28/2013 | WO2013175237A1 Composition comprising a cd2 ligation agent and a nkg2d ligation agent |
| 11/28/2013 | WO2013174982A1 Micro-engineered hydrogels |
| 11/28/2013 | WO2013174948A1 Process for multi-analyses of rare cells extracted or isolated from biological samples through filtration |
| 11/28/2013 | WO2013174889A1 Novel drosophila s2 cell line |
| 11/28/2013 | WO2013174794A1 Compositions and methods of obtaining and using endoderm and hepatocyte cells |
| 11/28/2013 | WO2013174769A1 Use of keratinocytes as a biologically active substance in the treatment of wounds, such as diabetic wounds, optionally in combination with a dpp-4 inhibitor |
| 11/28/2013 | WO2013173906A1 Collagenous foam materials |
| 11/28/2013 | WO2013119964A3 Identification and enrichment of cell subpopulations |
| 11/28/2013 | WO2009036095A8 Engineered light-harvesting organisms |
| 11/28/2013 | US20130318651 Poblano pepper line 347 |
| 11/28/2013 | US20130318650 Jalapeno pepper line 437 |
| 11/28/2013 | US20130318647 Pea line ex 08570957 |
| 11/28/2013 | US20130318646 Holon lettuce variety |
| 11/28/2013 | US20130318640 Vitamin k epoxide recycling polypeptide vkorc1, a therapeutic target of coumarin and their derivatives |
| 11/28/2013 | US20130317072 Method To Enhance Delivery Of Glutathione And ATP Levels In Cells |
| 11/28/2013 | US20130316455 Method of isolating cells from a tissue in a mammal |
| 11/28/2013 | US20130316454 Methods for Producing Tissue Scaffold Directing Differentiation of Seeded Cells and Tissue Scaffolds Produced Thereby |
| 11/28/2013 | US20130316453 Composition for Enhancing Cellular Uptake of Carrier Particles and Method for the Same |
| 11/28/2013 | US20130316452 Modalities for the treatment of degenerative diseases of the retina |
| 11/28/2013 | US20130316451 Modalities for the treatment of degenerative diseases of the retina |
| 11/28/2013 | US20130316445 Automated method and apparatus for embryonic stem cell culture |
| 11/28/2013 | US20130316434 Animal Protein Free Media for Cultivation of Cells |
| 11/28/2013 | US20130316387 Alginate hydrogel fibers and related materials |
| 11/28/2013 | US20130316373 Separation of living untouched neurons |
| 11/28/2013 | US20130316357 Pdx1-expressing dorsal and ventral foregut endoderm |
| 11/28/2013 | US20130316353 Culture method for obtaining a clonal population of antigen-specific b cells |
| 11/28/2013 | US20130316025 Cranberry Xyloglucan Oligosaccharide Composition |
| 11/28/2013 | US20130316004 Compositions and methods for stabilizing susceptible compounds |
| 11/28/2013 | US20130315942 WDRPUH Epitope Peptides and Vaccines Containing the Same |
| 11/28/2013 | US20130315939 Use of Cytokines and Mitogens to Inhibit Pathological Immune Responses |
| 11/28/2013 | US20130315938 Delivering polypeptides to phagocytes |
| 11/28/2013 | US20130315882 Stem Cell Aggregates and Methods for Making and Using |
| 11/28/2013 | US20130315880 Abcb5 positive mesenchymal stem cells as immunomodulators |
| 11/28/2013 | US20130315879 Method for expansion of stem cells and the use of such cells |
| 11/28/2013 | US20130315876 Differentiation of human embryonic and induced pluripotent stem cells |
| 11/28/2013 | US20130315828 Kit and method of use of targeting peptide for diagnosis and therapy of cancer |
| 11/28/2013 | US20130313735 Electrospun Calcium Phosphate Nanofibers |
| 11/28/2013 | DE10144906B4 Verfahren zur großtechnischen Herstellung von Impfstoffen A process for the large scale production of vaccines |
| 11/27/2013 | EP2667191A1 Method for evaluation of regenerated cartilage |
| 11/27/2013 | EP2666864A1 Genes that increase plant oil and method for using the same |
| 11/27/2013 | EP2666863A1 Genes that increase plant oil and method for using the same |
| 11/27/2013 | EP2666862A1 Genes that increase plant oil and method for using the same |
| 11/27/2013 | EP2666861A1 Genes that increase plant oil and method for using the same |
| 11/27/2013 | EP2666860A1 Genes that increase plant oil and method for using the same |
| 11/27/2013 | EP2666857A1 Nucleic acid construct for expressing oxidative stress indicator and use thereof |
| 11/27/2013 | EP2666852A1 Anti-apoptosis or anti-necrosis induction method |
| 11/27/2013 | EP2666851A1 Gene capable of regulating obesity/insulin sensitivity |
| 11/27/2013 | EP2666783A2 Compositions and methods for inhibiting interleukin-23 pathways |
| 11/27/2013 | EP2666486A1 Micro-engineered hydrogels |
| 11/27/2013 | EP2666466A1 Process for production of nk-cell-enriched blood preparation |
| 11/27/2013 | EP2665821A1 S/mar containing expression vectors, cell and cell lines as well as methods using the same |
| 11/27/2013 | EP2665811A1 Somatic cells with innate potential for pluripotency |